CNS Pharmaceuticals, Inc. (CNSP)
USD 0.11
(0.0%)
USD 0.11
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.14 Million | -10.55 Million | -13.53 Million | -7.31 Million | -3.55 Million | -716.38 Thousand |
| Net Income | -18.85 Million | -15.27 Million | -14.03 Million | -9.45 Million | -3.87 Million | -7.39 Million |
| Depreciation & Amortization | 4134.00 | 11.75 Thousand | 13.07 Thousand | 11.09 Thousand | 1955.00 | - |
| Deferred income taxes | -1.32 Million | - | -714.86 Thousand | - | - | - |
| Stock-based compensation | 1 Million | 1.2 Million | 1.72 Million | 1.29 Million | 477.09 Thousand | 110.24 Thousand |
| Change in working capital | 3.69 Million | 3.16 Million | -1.23 Million | 833.78 Thousand | -425.61 Thousand | 83.77 Thousand |
| Other non-cash items | 1.32 Million | 337.24 Thousand | 714.86 Thousand | 1583.00 | 270.3 Thousand | 6.48 Million |
| Investing Cash Flow | -3901.00 | -4422.00 | -5748.00 | -17.94 Thousand | -20.12 Thousand | - |
| Investments in PPE | -3901.00 | -4422.00 | -5748.00 | -17.94 Thousand | -20.12 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 4.63 Million | 15.61 Million | 4.5 Million | 14.13 Million | 10.25 Million | 1.16 Million |
| Debt repayment | -438.73 Thousand | -427.7 Thousand | -477.49 Thousand | -43.08 Thousand | -35 Thousand | -183.8 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5.07 Million | 16.03 Million | 4.65 Million | 14.22 Million | 10.29 Million | 390.5 Thousand |
| Other Financing Activities | -202.85 Thousand | 2734.00 | 332.75 Thousand | -45 Thousand | 10.25 Thousand | 770.47 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.32 Million | 1.7 Million | 576.49 Thousand | 656.83 Thousand | 153.6 Thousand | 71.36 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.37 Million | 1.46 Million | -1.81 Million | 176.95 Thousand | -579.22 Thousand | 12.4 Thousand |
| Cash at beginning of period | 10.05 Million | 5 Million | 14.03 Million | 7.24 Million | 555.13 Thousand | 110.54 Thousand |
| Cash at end of period | 548.72 Thousand | 10.05 Million | 5 Million | 14.03 Million | 7.24 Million | 555.13 Thousand |
| Capital Expenditure | -3901.00 | -4422.00 | -5748.00 | -17.94 Thousand | -20.12 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -9.5 Million | 5.05 Million | -9.03 Million | 6.79 Million | 6.68 Million | 444.59 Thousand |
| Free Cash Flow | -14.14 Million | -10.56 Million | -13.54 Million | -7.33 Million | -3.57 Million | -716.38 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.53 Million | -3.54 Million | -5.37 Million | -18.85 Million | -4.52 Million | -4.02 Million |
| Depreciation & Amortization | 752.00 | 818.00 | 953.00 | 4134.00 | 899.00 | 1003.00 |
| Deferred income taxes | - | - | -234.58 Thousand | -1.32 Million | - | 498.35 Thousand |
| Stock-based compensation | 234.34 Thousand | 202.93 Thousand | 232.67 Thousand | 1 Million | 194.75 Thousand | 289.67 Thousand |
| Change in working capital | 645.26 Thousand | 149.13 Thousand | 2.6 Million | 3.69 Million | 950.06 Thousand | 327.79 Thousand |
| Other non-cash items | 235.84 Thousand | 204.37 Thousand | 234.32 Thousand | 1.32 Million | 757.00 | -498.35 Thousand |
| Investing Cash Flow | - | - | -2157.00 | -3901.00 | -1744.00 | - |
| Investments in PPE | 3.00 | - | -2157.00 | -3901.00 | -1744.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.32 Million | 3.45 Million | 2.17 Million | 4.63 Million | 8359.00 | 2.57 Million |
| Debt repayment | -89.85 Thousand | -87.7 Thousand | -70.66 Thousand | -438.73 Thousand | -124.49 Thousand | -122.67 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.43 Million | 3.54 Million | 2.24 Million | 5.07 Million | 132.85 Thousand | 1.96 Million |
| Other Financing Activities | 2.32 Million | -75.29 Thousand | 2177.68 | -202.85 Thousand | 8.36 | 725.05 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | 46.13 Thousand | 1.43 Million | 1.32 Million | - | 790.03 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -116.06 Thousand | 149.13 Thousand | 2.6 Million | 2.37 Million | 950.06 Thousand | -462.24 Thousand |
| Cash at beginning of period | 815.22 Thousand | 548.72 Thousand | 909.54 Thousand | 10.05 Million | 4.27 Million | 5.11 Million |
| Cash at end of period | 1.49 Million | 815.22 Thousand | 548.72 Thousand | 548.72 Thousand | 909.54 Thousand | 4.27 Million |
| Capital Expenditure | 3.00 | - | -2157.00 | -3901.00 | -1744.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 676.33 Thousand | 266.5 Thousand | -360.82 Thousand | -9.5 Million | -3.36 Million | -831.28 Thousand |
| Free Cash Flow | -1.65 Million | -3.19 Million | -2.53 Million | -14.14 Million | -3.37 Million | -3.4 Million |
SKY
IFA
BETSF
2886
4197
601318